SWOG clinical trial number
SWOG-8708
Treatment of Hormonally Refractory Stage D Carcinoma of the Prostate with CHIP
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Treatment of Hormonally Refractory Stage D Carcinoma of the Prostate with CHIP
Activated
04/01/1989
Closed
09/01/1990
Publication Information Expand/Collapse
1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
1994
Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: A Southwest Oncology Group report.